Filtravate, founded with the core mission to revolutionize membrane technology, focuses on developing and commercializing ultrafiltration membranes specifically for the bioprocessing and biopharmaceutical industries. The company leverages patent-pending technology exclusively licensed from New Mexico State University (NMSU) to create membranes with controlled and tunable pore sizes, even pore distribution, and functionalized surfaces. Filtravate aims to set new standards in filtration efficiency and reliability, addressing critical needs in its target markets.

Notable affiliated individuals include researchers and innovators from NMSU who contributed to the foundational technology. Filtravate has garnered attention for its innovative approach to membrane construction, earning recognition within the industry for its potential to significantly enhance bioprocessing workflows. The company's impact is reflected in its ability to offer advanced filtration solutions that promise improved performance and cost-effectiveness for biopharmaceutical manufacturers.